Effect of rearing system intensiveness on biological features, culture performance and larval quality of meagre (Argyrosomus regius Asso, 1801) larvae

[EN]Meagre, Argyrosomus regius A., is a new species for aquaculture in south Atlantic and Mediterranean regions, that can reach a mean fresh weight of 8.02±2.51g. at 95dah. However, hatchery techniques must be improved to optimize culture performance and larval quality. Eggs of meagre were cultured under intensive (75 indv.l-1 in 2m3 tanks) and semi-intensive system (7.5 indv.l-1 in 40m3 tanks) to evaluate the effect of the intensification on biological features, stress resistance and skeletal deformities. At 30dah, despite in semi-intensive system reared larvae a higher total length (19.08± 2.3mm vs 16.00±1.54mm), dry body weight (13.09± 2.43mg vs 6.46±0.52mg), and survival after the activity test (75.0± 13.8% vs 53.3±11.5%) was found, the use of intensive systems were also very suitable and cost-effective for larval rearing of this species

Erythropoietin treatment elevates haemoglobin concentration by increasing red cell volume and depressing plasma volume

[EN] Erythropoietin (Epo) has been suggested to affect plasma volume, and would thereby possess a mechanism apart from erythropoiesis to increase arterial oxygen content. This, and potential underlying mechanisms, were tested in eight healthy subjects receiving 5000 IU recombinant human Epo (rHuEpo) for 15 weeks at a dose frequency aimed to increase and maintain haematocrit at approximately 50%. Red blood cell volume was increased from 2933 +/- 402 ml before rHuEpo treatment to 3210 +/- 356 (P < 0.01), 3117 +/- 554 (P < 0.05), and 3172 +/- 561 ml (P < 0.01) after 5, 11 and 13 weeks, respectively. This was accompanied by a decrease in plasma volume from 3645 +/- 538 ml before rHuEpo treatment to 3267 +/- 333 (P < 0.01), 3119 +/- 499 (P < 0.05), and 3323 +/- 521 ml (P < 0.01) after 5, 11 and 13 weeks, respectively. Concomitantly, plasma renin activity and aldosterone concentration were reduced. This maintained blood volume relatively unchanged, with a slight transient decrease at week 11, such that blood volume was 6578 +/- 839 ml before rHuEpo treatment, and 6477 +/- 573 (NS), 6236 +/- 908 (P < 0.05), and 6495 +/- 935 ml (NS), after 5, 11 and 13 weeks of treatment. We conclude that Epo treatment in healthy humans induces an elevation in haemoglobin concentration by two mechanisms: (i) an increase in red cell volume; and (ii) a decrease in plasma volume, which is probably mediated by a downregulation of the rennin-angiotensin-aldosterone axis. Since the relative contribution of plasma volume changes to the increments in arterial oxygen content was between 37.9 and 53.9% during the study period, this mechanism seems as important for increasing arterial oxygen content as the well-known erythropoietic effect of Epo.